“Sub potent” thyroid medication recalled by Acella Pharmaceuticals
Acella Pharmaceuticals has voluntarily recalled 2 (two) lots of their thyroid medication because it was found to be “sub potent”, or not strong enough. The drug is prescribed to those with hypothyroidism (an underactive thyroid). The recalled prescription was distributed nationwide, and sold in 100 count bottles.
15 mg tablets
Lot Number: M327E19-1
Expires: October 2020
NDC Number: 42192-327-01
120 mg tablets
Lot Number: M328F19-3
Expires: November 2020
NDC Number: 42192-328-01
So far, there are reports of “at least 4” people suffering from adverse effects of the recalled drugs. Taking sub potent thyroid medication is especially concerning for newborns and pregnant women. If you’ve been prescribed the recalled drug, the U.S. Food and Drug Administration warns that you could, “experience signs and symptoms of hypothyroidism, which may include, fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight."
To read the full recall news from Fox 10 Phoenix, click here: https://bit.ly/2SsMBCl